647 filings
Page 5 of 33
DEFA14A
dv2bch3e3wwqvr8e
12 Sep 19
Additional proxy soliciting materials
8:14am
8-K
8nki7mb
12 Sep 19
Other Events
8:09am
PREC14A
kf8jo73 0ri2s
10 Sep 19
Preliminary proxy with contested solicitation
9:04am
DEFA14A
xkgxys
4 Sep 19
Additional proxy soliciting materials
9:10pm
DEFA14A
ole1mh647agk ebe
4 Sep 19
Additional proxy soliciting materials
5:30pm
DFAN14A
tu6a98f 9wdng
4 Sep 19
Additional proxy materials by non-management
8:30am
PREC14A
w0pdj
4 Sep 19
Preliminary proxy with contested solicitation
8:00am
8-K
yawd2se5h zi2ejgwtvc
7 Aug 19
Amag Pharmaceuticals Announces Second Quarter 2019 Financial Results
7:02am
8-K
jhkj1mur8pildx04yil
24 Jun 19
The First FDA-Approved As-Needed Treatment for Premenopausal Women Experiencing Distress or Interpersonal Difficulty Due to Low Sexual Desire
12:00am
8-K
j3wxmsoqbrkijk1
22 May 19
Regulation FD Disclosure
7:28am
8-K
cvo8kbjmejp8jop d53
17 May 19
Departure of Directors or Certain Officers
8:53am
S-8
9vpyr o5w
16 May 19
Registration of securities for employees
4:43pm
8-K
y2x6sw1
7 May 19
Amag Pharmaceuticals Announces First Quarter 2019 Financial Results
7:04am
8-K
xj57lkokky
12 Apr 19
Amag Pharmaceuticals Appoints New Members to Board of Directors
8:05am
8-K
a9tfkf9itg5uizkhfoh9
4 Apr 19
Departure of Directors or Certain Officers
8:32am
8-K
7st1mf ph
8 Mar 19
Amag Pharmaceuticals Announces Topline Results from the Prolong Trial
8:04am
CT ORDER
mbalnj3p
5 Mar 19
Confidential treatment order
11:06am